FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000683717> ?p ?o ?g. }

• W2000683717 endingPage "1016" @default.
• W2000683717 startingPage "1005" @default.
• W2000683717 abstract "T-cell targeting immunotherapy is now considered as a possible strategy in the treatment of acute myelogenous leukaemia (AML). Clinical importance of antileukaemic T-cell reactivity after allogeneic stem cell transplantation (SCT) is well established and the early experience from IL-2 therapy suggests that even autologous T-cells can mediate antileukaemic reactivity. The clinical experience also indicates that immunotherapy should begin when the leukaemia cell burden is minimal, and the detection of an operative cellular immune system, even in patients with chemotherapy-induced cytopenia, further suggests that it is possible to begin T-cell targeting therapy early after chemotherapy while patients are still cytopenic. However, adult patients in particular have a T-cell defect after chemotherapy that may last for several months. For this reason immunotherapy should probably be continued or repeated until a maximal effect is achieved when the patients no longer have a T-cell defect. This treatment approach may also be considered in combination with autologous SCT. T-cell targeting regimens should include, if possible, several therapeutic components. Firstly, native AML blasts can function as accessory cells during T-cell activation and in vivo therapy with T-cell growth factors (e.g., IL-2, IL-15) may then enhance antileukaemic reactivity or non-specific cytotoxicity against the AML cells; and secondly, a further enhancement of AML-specific reactivity may be achieved by vaccination with AML-specific peptides, immunisation with AML-blasts expressing a dendritic cell phenotype, or exposure to normal antigen-presenting cells (APC) pulsed with or expressing AML-specific peptide sequences." @default.
• W2000683717 created "2016-06-24" @default.
• W2000683717 creator A5010194488 @default.
• W2000683717 creator A5021294750 @default.
• W2000683717 date "2001-11-01" @default.
• W2000683717 modified "2023-10-18" @default.
• W2000683717 title "Biological treatment in acute myelogenous leukaemia: how should T-cell targeting immunotherapy be combined with intensive chemotherapy?" @default.
• W2000683717 cites W1481612531 @default.
• W2000683717 cites W1519562949 @default.
• W2000683717 cites W1553402788 @default.
• W2000683717 cites W1707184873 @default.
• W2000683717 cites W1873141201 @default.
• W2000683717 cites W1965693792 @default.
• W2000683717 cites W1974020470 @default.
• W2000683717 cites W1976329458 @default.
• W2000683717 cites W1987064072 @default.
• W2000683717 cites W1988580189 @default.
• W2000683717 cites W1992238854 @default.
• W2000683717 cites W1992722717 @default.
• W2000683717 cites W1996658897 @default.
• W2000683717 cites W1999296675 @default.
• W2000683717 cites W2002478729 @default.
• W2000683717 cites W2007725310 @default.
• W2000683717 cites W2011768640 @default.
• W2000683717 cites W2013051826 @default.
• W2000683717 cites W2014057016 @default.
• W2000683717 cites W2016857765 @default.
• W2000683717 cites W2020661968 @default.
• W2000683717 cites W2023485889 @default.
• W2000683717 cites W2032969485 @default.
• W2000683717 cites W2033765628 @default.
• W2000683717 cites W2038871123 @default.
• W2000683717 cites W2040735196 @default.
• W2000683717 cites W2044311624 @default.
• W2000683717 cites W2046854756 @default.
• W2000683717 cites W2056644883 @default.
• W2000683717 cites W2060143975 @default.
• W2000683717 cites W2074677944 @default.
• W2000683717 cites W2075810280 @default.
• W2000683717 cites W2076146641 @default.
• W2000683717 cites W2079801336 @default.
• W2000683717 cites W2080397334 @default.
• W2000683717 cites W2082081599 @default.
• W2000683717 cites W2087417521 @default.
• W2000683717 cites W2092301381 @default.
• W2000683717 cites W2094292853 @default.
• W2000683717 cites W2098854099 @default.
• W2000683717 cites W2108238886 @default.
• W2000683717 cites W2117291755 @default.
• W2000683717 cites W2123434358 @default.
• W2000683717 cites W2145438823 @default.
• W2000683717 cites W2150113701 @default.
• W2000683717 cites W2154083433 @default.
• W2000683717 cites W2168159922 @default.
• W2000683717 cites W2183646837 @default.
• W2000683717 cites W2206440253 @default.
• W2000683717 cites W2217873455 @default.
• W2000683717 cites W2222947433 @default.
• W2000683717 cites W2235951807 @default.
• W2000683717 cites W2246326369 @default.
• W2000683717 cites W2290604176 @default.
• W2000683717 cites W2317818796 @default.
• W2000683717 cites W2318674152 @default.
• W2000683717 cites W2320682501 @default.
• W2000683717 cites W2322548232 @default.
• W2000683717 cites W2324236363 @default.
• W2000683717 cites W2326876185 @default.
• W2000683717 cites W2333208169 @default.
• W2000683717 cites W2406871555 @default.
• W2000683717 cites W2461953138 @default.
• W2000683717 cites W39579847 @default.
• W2000683717 cites W4248626267 @default.
• W2000683717 cites W4312790597 @default.
• W2000683717 cites W4385970358 @default.
• W2000683717 cites W91179974 @default.
• W2000683717 doi "https://doi.org/10.1517/14712598.1.6.1005" @default.
• W2000683717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11728232" @default.
• W2000683717 hasPublicationYear "2001" @default.
• W2000683717 type Work @default.
• W2000683717 sameAs 2000683717 @default.
• W2000683717 citedByCount "26" @default.
• W2000683717 countsByYear W20006837172013 @default.
• W2000683717 countsByYear W20006837172021 @default.
• W2000683717 countsByYear W20006837172022 @default.
• W2000683717 crossrefType "journal-article" @default.
• W2000683717 hasAuthorship W2000683717A5010194488 @default.
• W2000683717 hasAuthorship W2000683717A5021294750 @default.
• W2000683717 hasConcept C10882517 @default.
• W2000683717 hasConcept C126322002 @default.
• W2000683717 hasConcept C203014093 @default.
• W2000683717 hasConcept C2776090121 @default.
• W2000683717 hasConcept C2776694085 @default.
• W2000683717 hasConcept C2777701055 @default.
• W2000683717 hasConcept C2780007613 @default.
• W2000683717 hasConcept C2780366003 @default.
• W2000683717 hasConcept C28328180 @default.
• W2000683717 hasConcept C502942594 @default.
• W2000683717 hasConcept C54355233 @default.

• next